TL117

· Suzhou Junde Biotechnology Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TL117, covering 2024-12-09 to 2024-12-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of TL117 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 1, Phase 2]